YN4-29289-72018
2 vaccinations
2 coded responses
2 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 662 / KS
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
SCW-90155-46236
Child or adolescent in my care · Female · 2022-06-27
NVH-19329-57977
Child or adolescent in my care · Male · 2022-07-13
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Dose 2 — Pfizer-BioNTech
-
2021-04-10
Registered in v-safe
-
2021-04-10
Survey response — day 14, dose 2MedDRA: Anxiety — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-23
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-10 | Unsuccessful |
Free text
Release 7 — day 14, dose 2
Symptoms: Increased anxiety
Release 9 — 6 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release